Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups. by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. by Ningning Wang (560944)

Subjects:

Data Sheet 1_Bletilla striata polysaccharides ameliorate metabolic-associated fatty liver disease by decreasing the NLRP3 inflammasome and pyroptosis.pdf by Tingting Yu (419018)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Multiple linear regression analysis results. by Muxi Chen (9294270)

Subjects:

Diagram of the mediating model of the relationship between increased inhibition in the increase of mindfulness level and the decrease of mobile phone addiction index. by Jizhao Li (5856650)

Estimation of the coefficients of a generalised linear model of posttraumatic stress symptomatology. by Beatriz Arregui-Gallego (21553735)

Subjects:

Linear trends of weekly prescription rates of NVBP varieties. by Chenxuan Zhu (22622476)

Table 1_Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris.docx by Agata Lesiak (17951854)

Population characteristics by quartiles of dietary niacin intake. by Yushan Shi (16440272)

Subjects:

Multivariate logistic regression analysis of dietary niacin for risk of COPD. by Yushan Shi (16440272)

Subjects:

Association of covariates and COPD risk. by Yushan Shi (16440272)

Subjects:

The relationship between dietary niacin intake and COPD stratified using different characteristics. by Yushan Shi (16440272)

Subjects:

Association between dietary niacin intake and COPD odds ratio. by Yushan Shi (16440272)

Subjects:

Flow diagram of study participants. by Yushan Shi (16440272)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

The role of LytA in functionally linking decreased NAM <i>O-</i>acetylation with <i>hsdS</i> inversions and colony phase. by Xiu-Yuan Li (3328056)